J&J Had ‘Inappropriate’ Risk Controls for Hip, Jury Told

Johnson & Johnson’s DePuy unit took “inappropriate” steps to identify and eliminate risks in the design of 93,000 all-metal hip implants that J&J recalled, a company compliance manager told a California jury.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.